Press Releases

OBIO Opens Canadian Health Investment Showcase in New York City, Connecting Canada’s High Potential Health Science Companies with Premier US Investors

The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce the opening of the Canadian Health Investment Showcase in New York, NY, on November 5 and 6, 2018.

The Canadian Health Investment Showcase will feature 18 of Canada’s highest potential companies meeting with more than 35 US investors and VCs in New York City to drive investment in Canada’s health science industry.

OBIO is excited by the opportunities for investments and partnerships that the Canadian Health Investment Showcase will create. The overwhelming desire from both US investors and Canadian companies to be part of the Showcase ensures that this event will create unparalleled prospects for both North America’s premier private equity investors and Canada’s most promising health science companies.
— Gail Garland, OBIO President and CEO

Over two days at the Consulate General of Canada in New York, the Canadian Health Investment Showcase features hundreds of one-on-one meetings between companies and US investors, as well as panel discussions on cross-border investing in the health science industry and a keynote on trends in health investing this year.

Creating a dynamic environment for health science companies to meet with targeted US health investors is an opportunity not just for individual companies but the entire Canadian health science industry. I am not only pleased to join the delegation of companies at the Canadian Health Investment Showcase but also to congratulate OBIO on delivering an unprecedented event focused on the needs of Canadian companies.
— Dr. Jeremy Bridge-Cook, CEO of Rna Diagnostic

To find out more, click here to read the full press release.

OBIO Announces 2018 CAAP® Cohort with 12 High Potential Health Science Companies

OBIO is proud to announce its 2018 Capital Access Advisory Program (CAAP®) and the 11 high-potential health companies in this year’s cohort. Now in its sixth year, this year’s OBIO CAAP companies will work with OBIO and a vast network of expert advisors over the next year to achieve key goals and objectives which will position them for successful financing.

Press Release: OBIO CAAP Companies Raise More Than $109 Million in Investments

Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit membership based organization that is Ontario’s leading advocate for the health science industry, announced today that Ontario health science companies that have participated in its Capital Access Advisory Program (CAAP®) have raised more than $109 Million since the CAAP program launched in 2013.

Ontario Bioscience Innovation Organization (OBIO®) Leadership Summit Hosts Top Health Science Minds to Define Future of the Industry

January 24, 2017 TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®) hosted a summit of industry, academic, government and investment leaders about the future of health science innovation in Canada. Attendees engaged in group discussions and heard from subject matter experts to extrapolate a mandate of action for anchoring health science companies in Ontario. The outcome of the summit lays a foundation for actionable business cases for private and public sector solutions to the health science industry’s biggest challenges: Innovation Pull, Adoption and Capital Attraction.

OBIO Announces New Public Relations & Communications Services Member Benefit

TORONTO, Dec. 7, 2016  - HOWE&WYE is proud to announce its new partnership with OBIO®. As a part of OBIO's new member benefit, HOWE&WYE will provide strategic public relations and communications services to OBIO's broad membership of world-class start-ups and bioscience companies. OBIO members will benefit from special access to top-tier agency support with optimized pricing to strengthen PR and marketing to fulfill strategic business outcomes for awareness, investment and commercialization.

OBIO® Launches the Health 2 Business Bridge Program™ H2BB™ Improving Access to Business Trained Talent in Ontario’s Health Science Industry

Toronto, Ontario, December 6, 2016 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit, membership based organization, that is Ontario’s leading advocate for the health science industry, hosted its Annual Public Meeting with the theme centered on “Bridging the Access to Talent Gap” at Norton Rose Fulbright LLP yesterday. The OBIO Annual Public Meeting provided a platform to highlight OBIO’s accomplishments made in 2016, upcoming initiatives for 2017 and an opportunity to hear from Parliamentary Assistant to the Minister of Economic Development and Growth, Cristina Martins and Members of the OBIO MPP Health Science Caucus, MPP Shafiq Qaadri and MPP Bill Walker, who welcomed networking with over 60 health science industry professionals.

The evening focused on a vision of collaboration across health science companies and highlighted the supportive partnership that the Province of Ontario has with OBIO.  The evening also marked the launch of the OBIO Health to Business Bridge™ H2BB™ internship program.  OBIO H2BB™ is a program in support of improving access to business trained talent in Ontario’s health science sector, ultimately contributing to a sustainable innovation economy. 

The H2BB™ internship program will combine OBIO’s deep-rooted relationships across academia and industry to develop industry ready talent that strengthens business development capabilities in Ontario’s health science companies, and ultimately amplifies the innovation capability of the province. 

OBIO’s ongoing dialogue with industry has identified access to industry ready business talent as a challenge for health science companies seeking to scale up and commercialize their technologies. The OBIO H2BB™ Program is intended to benefit all participants, interns and industry companies alike, to facilitate development of our knowledge economy and create leadership that understands emerging technology trends to ultimately achieve multipliers of job creation.
— Gail Garland, CEO, OBIO

OBIO H2BB™ provides companies with a unique opportunity to access new talent, while assisting with critical business projects.  Interns will rapidly develop knowledge and insight into new and ultimately profitable technologies. 

Program Participation

Participation in OBIO H2BB™ is open to all Ontario companies developing health science products or services, who are interested in hiring a business trained intern to help complete a managerial project for a minimum duration of four-months. Interested companies are encouraged to contact OBIO to discuss their interest. 

About OBIO

The Ontario Bioscience Innovation Organization (OBIO®) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario and one that will become a global leader in providing health technology products and services to the international marketplace.  OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government.

For more information, visit the OBIO website www.obio.ca and follow OBIO on Twitter @OBIOscience.

OBIO Contacts

Eric Dolinar
Program Manager, Health to Business Bridge
ericdolinar@obio.ca
416-848-6839 ext. 107     

Gail Garland
President and Chief Executive Officer, OBIO
gailgarland@obio.ca
416-848-6839 ext. 101

Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2017 Capital Access Advisory Program

Toronto, Ontario, November 2, 2016 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit, organization that is Ontario’s leading advocate for the health science industry, is pleased to announce a call for applications for the 2017 OBIO Capital Access Advisory Program (CAAP®).